Vasso apostolopoulos (40 Ergebnisse)

Zustand: New. In English.

Zustand: New. In English.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: NEW.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New. In English.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Zustand: Brand New. 350 pages. 9.21x7.50x1.02 inches. In Stock.

Zustand: New. Offers comprehensive coverage of different vaccine platforms and their developmentIncludes information on the regulatory perspective of vaccine developmentDescribes different delivery approaches for vaccinologyExplains the.

Zustand: New. 2024. 1st Edition. paperback. . . . . . Books ship from the US and Ireland.

Zustand: New.

Zustand: New.

Zustand: New. In English.

Paperback. Zustand: Brand New. 225 pages. 10.75x8.50x1.00 inches. In Stock.

Taschenbuch. Zustand: Neu. Advanced Vaccination Technologies for Infectious and Chronic Diseases | A guide to Vaccinology | Lalitkumar K. Vora (u. a.) | Taschenbuch | Developments in Immunology | Einband - flex.(Paperback) | Englisch | 2024 | Elsevier Science Publishing Co Inc | EAN 9780443185649 | Verantwortliche Person für die EU: Elsevier B.V., Radarweg 29, 1043 NX AMSTERDAM, NIEDERLANDE, productsafety[at]elsevier[dot]com | Anbieter: preigu.…

Gebunden. Zustand: New. Vivek Chavda, M. Pharm, is an assistant professor in the Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Ahmedabad, India. He has more than 40 research articles in international journals.Krishnan Anand, PhD, is a resear.

Zustand: New. Vivek P. Chavda is an assistant professor in the Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad, India. He is BPharm and MPharm Gold medalist at Gujarat Technological University. Before joining academia, he ser.

Zustand: New.

Zustand: New. In English.

Zustand: New. In English.

Hardcover. Zustand: Brand New. 400 pages. 11.02x8.66x2.76 inches. In Stock.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Taschenbuch. Zustand: Neu. Neuware - Advanced Vaccination Technologies for Infectious and Chronic Diseases is a comprehensive guide that delves into the intricate details of vaccine design, development across various platforms, and the path to commercialization. This book provides an introductory overview of vaccines, covering various types, developmental methodologies, delivery systems, adjuvants, immunization, and measurement of vaccine efficacy. It also showcases examples of vaccine research efforts targeting infectious diseases, autoimmune disorders, and cancer. The book concludes by exploring cutting-edge advances in proteogenomics, immunopeptidomics, and future vaccine technologies.The primary objective of this book is to inform a broad scientific audience about the fundamental concepts underlying vaccine and immunology. Further, it serves as an invaluable reference for understanding the critical steps in the journey from discovery to regulatory processes for human clinical trials, addressing common misconceptions and presenting factual information about vaccinations. Advanced Vaccination Technologies for Infectious and Chronic Diseases is a requisite reference for occupational health professionals whose roles involve supervision of immunization programs such as those working within the National Health Service, some sectors of higher education, or the pharmaceutical industry. It also caters to those researchers engaged in vaccine development and all who want to learn the processes involved from laboratory research to final product.…

Hardcover. Zustand: Brand New. 1st edition. 386 pages. 9.00x6.00x1.25 inches. In Stock.

Hardcover. Zustand: Brand New. anv edition. 494 pages. 9.50x6.50x1.25 inches. In Stock.

Paperback. Zustand: Brand New. 350 pages. 9.21x7.50x1.02 inches. In Stock.

Buch. Zustand: Neu. Neuware - The book is essential for anyone interested in vaccine development, as it highlights the unique advantages of viral vector vaccines in triggering robust, long-lasting immunity and provides an in-depth exploration of the technology and advancements shaping the future of healthcare. Viral vector vaccines have several unique advantages when compared to other vaccine platforms. These powerful vaccines are capable of triggering long-lasting cellular responses, such as cytotoxic T-lymphocytes, that eradicate virus-infected cells. Viral vector-based vaccines use a harmless virus to smuggle the instructions for making antigens from the disease-causing virus into cells, triggering protective immunity against them. In contrast to conventional antigen-containing vaccines, these vaccines use the body's natural defense system to produce antigens by using a modified virus to deliver genetic code for an antigen. Viral Vectors for Vaccine Delivery provides a comprehensive overview of viral vectors and their applications in vaccine delivery. Its chapters explore various aspects of viral vector technology, from the basic principles of viral vector construction to the latest advancements in gene editing and manufacturing. Readers will find that the book - Offers a deep dive into the world of viral vectors, covering their principles, applications, and potential impact on healthcare; - Explores how viral vectors are revolutionizing vaccine development, providing a more effective and targeted approach to disease prevention; - Discusses the potential of viral vectors to address emerging health challenges and contribute to a healthier world. Audience Research scholars, pharma-process engineers, research scientists, pharmacy students and professionals from the pharmaceutical and biopharmaceutical industry interested in drug discovery, chemical biology, computational chemistry, medicinal chemistry, and bioinformatics.…

Zustand: New. 2025. 1st Edition. hardcover. . . . . . Books ship from the US and Ireland.